Blue Cap AG, a Munich-based investment company, has announced a significant change to its management board. The Supervisory Board and Chairman of the Management Board, Dr Henning von Kottwitz, have mutually agreed that Dr von Kottwitz will leave the company at the end of 8 October 2026. The Supervisory Board expressed its gratitude for his service and commitment. The company stated that it is well positioned for further development, particularly due to transactions implemented in recent years under Dr von Kottwitz's leadership.
Following his departure, the Supervisory Board has resolved to second its Chairman, Dr Christian Diekmann, to the Management Board as a member with effect from 9 October 2026, pursuant to Section 105(2) of the German Stock Corporation Act (AktG). Dr Diekmann will be responsible for strategy and finance. Henning Eschweiler will remain a member of the Management Board as COO, continuing to oversee operational portfolio management, and will also assume responsibility for M&A starting 9 October 2026.
Dr Christian Diekmann has been Chairman of the Supervisory Board of Blue Cap AG since 2024. He brings extensive experience in operational restructuring of medium-sized companies and management of medium-sized corporate groups. He previously served as CEO of the listed Max Automation SE and CFO of the family-owned Zertus Group. "We are very pleased that Dr Christian Diekmann has agreed to drive the further development of Blue Cap AG's business model as a member of the Management Board in the near term and take it to the next level," said Dr Michael Schieble, Deputy Chairman of the Supervisory Board. "As Chairman of the Supervisory Board, he has in-depth knowledge of Blue Cap and understands its potential as a listed investment company pursuing the successful Buy-Transform-Sell strategy."
Dr Diekmann commented, "Blue Cap AG is ideally positioned as an investor in 'special situations' to grow in the current economic environment. Many companies that are fundamentally well positioned for the future are increasingly affected by disruptions in industry and structural challenges. We aim to address these challenges through our business model, strengthen Germany as an industrial location and create value for our shareholders. In my new role, I look forward to working even more closely with Blue Cap AG's highly qualified team."
Blue Cap AG is a publicly traded investment company founded in 2006 and headquartered in Munich. It acquires medium-sized B2B companies in special situations and supports their business development, aiming to sell them at a profit later. The acquired companies are based in the DACH region, generate revenues between EUR 20 million and EUR 200 million, and have stable core businesses. Blue Cap currently holds majority stakes in six portfolio companies operating in plastics engineering, production engineering, pre-press solutions, life sciences, and business services. The group employs around 2,000 people in Germany, Europe, North America, and Asia. Its shares trade on the Open Market (Scale, Frankfurt, and m:access, Munich; ISIN: DE000A0JM2M1; ticker symbol: B7E). For more information, visit www.blue-cap.de. The original release can be viewed on www.newmediawire.com.
This leadership transition is important for investors and the industry as Blue Cap AG continues its Buy-Transform-Sell strategy under new management. Dr Diekmann's operational expertise and deep knowledge of the company position it to navigate economic challenges and create shareholder value.
